Does race predict the development of metastases in men who receive androgen‐deprivation therapy for a biochemical recurrence after radical prostatectomy? (Englisch)
- Neue Suche nach: Vidal, Adriana C.
- Neue Suche nach: Howard, Lauren E.
- Neue Suche nach: De Hoedt, Amanda
- Neue Suche nach: Kane, Christopher J.
- Neue Suche nach: Terris, Martha K.
- Neue Suche nach: Aronson, William J.
- Neue Suche nach: Cooperberg, Matthew R.
- Neue Suche nach: Amling, Christopher L.
- Neue Suche nach: Lechpammer, Stanislav
- Neue Suche nach: Flanders, Scott C.
- Neue Suche nach: Freedland, Stephen J.
- Neue Suche nach: Vidal, Adriana C.
- Neue Suche nach: Howard, Lauren E.
- Neue Suche nach: De Hoedt, Amanda
- Neue Suche nach: Kane, Christopher J.
- Neue Suche nach: Terris, Martha K.
- Neue Suche nach: Aronson, William J.
- Neue Suche nach: Cooperberg, Matthew R.
- Neue Suche nach: Amling, Christopher L.
- Neue Suche nach: Lechpammer, Stanislav
- Neue Suche nach: Flanders, Scott C.
- Neue Suche nach: Freedland, Stephen J.
In:
Cancer
;
125
, 3
;
434-441
;
2019
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Does race predict the development of metastases in men who receive androgen‐deprivation therapy for a biochemical recurrence after radical prostatectomy?
-
Beteiligte:Vidal, Adriana C. ( Autor:in ) / Howard, Lauren E. ( Autor:in ) / De Hoedt, Amanda ( Autor:in ) / Kane, Christopher J. ( Autor:in ) / Terris, Martha K. ( Autor:in ) / Aronson, William J. ( Autor:in ) / Cooperberg, Matthew R. ( Autor:in ) / Amling, Christopher L. ( Autor:in ) / Lechpammer, Stanislav ( Autor:in ) / Flanders, Scott C. ( Autor:in )
-
Erschienen in:Cancer ; 125, 3 ; 434-441
-
Verlag:
-
Erscheinungsdatum:01.02.2019
-
Format / Umfang:8 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 125, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 321
-
Issue Information| 2019
- 329
-
First person profile: James Armitage, MDPrintz, Carrie et al. | 2019
- 330
-
Cancer treatment costs found to be higher for people younger than 65 YearsPrintz, Carrie et al. | 2019
- 331
-
Black women less likely to adhere to hormone therapy for breast cancerPrintz, Carrie et al. | 2019
- 332
-
Indications for and efficacy of postmastectomy radiotherapy for patients with a favorable response to neoadjuvant chemotherapyFrancis, David M. / Witt, Jacob S. / Anderson, Bethany M. et al. | 2019
- 335
-
More evidence on the limited impact of state oral oncology parity lawsWinn, Aaron N. / Dusetzina, Stacie B. et al. | 2019
- 337
-
Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiencyEskander, Ramez N. et al. | 2019
- 340
-
Oligometastatic prostate cancer: Reality or figment of imagination?Foster, Corey C. / Weichselbaum, Ralph R. / Pitroda, Sean P. et al. | 2019
- 353
-
The role of neuro‐immune interactions in cancer‐related fatigue: Biobehavioral risk factors and mechanismsBower, Julienne E. et al. | 2019
- 365
-
Feasibility of fine‐needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry studyCaudle, Abigail S. / Kuerer, Henry M. / Krishnamurthy, Savitri / Shin, Kyungmin / Hobbs, Brian P. / Ma, Junsheng / Mittendorf, Elizabeth A. / Washington, Ashley C. / DeSnyder, Sarah M. / Black, Dalliah M. et al. | 2019
- 374
-
The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancerChin, Alexander L. / Bentley, Jason P. / Pollom, Erqi L. et al. | 2019
- 382
-
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited‐stage small cell lung cancer in elderly patients versus younger patientsStinchcombe, Thomas E. / Fan, Wen / Schild, Steven E. / Vokes, Everett E. / Bogart, Jeff / Le, Quynh‐Thu / Thomas, Charles R. / Edelman, Martin J. / Horn, Leora / Komaki, Ritsuko et al. | 2019
- 391
-
Outcomes of very high‐risk prostate cancer after radical prostatectomy: Validation study from 3 centersSundi, Debasish / Tosoian, Jeffrey J. / Nyame, Yaw A. / Alam, Ridwan / Achim, Mary / Reichard, Chad A. / Li, Jianbo / Wilkins, Lamont / Schwen, Zeyad / Han, Misop et al. | 2019
- 398
-
Mismatch repair deficiency identifies patients with high‐intermediate–risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarkerBackes, Floor J. / Haag, Jennifer / Cosgrove, Casey M. / Suarez, Adrian / Cohn, David E. / Goodfellow, Paul J. et al. | 2019
- 406
-
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs dataBauml, Joshua M. / Vinnakota, Ravi / Anna Park, Yeun‐Hee / Bates, Susan E. / Fojo, Tito / Aggarwal, Charu / Di Stefano, Jessica / Knepley, Christina / Limaye, Sewanti / Mamtani, Ronac et al. | 2019
- 416
-
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agentsMina, Roberto / Joseph, Nisha S. / Kaufman, Jonathan L. / Gupta, Vikas A. / Heffner, Leonard T. / Hofmeister, Craig C. / Boise, Lawrence H. / Dhodapkar, Madhav V. / Gleason, Charise / Nooka, Ajay K. et al. | 2019
- 424
-
Phase 1 lead‐in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastomaMaraka, Stefania / Groves, Morris D. / Mammoser, Aaron G. / Melguizo‐Gavilanes, Isaac / Conrad, Charles A. / Tremont‐Lukats, Ivo W. / Loghin, Monica E. / O’Brien, Barbara J. / Puduvalli, Vinay K. / Sulman, Erik P. et al. | 2019
- 434
-
Does race predict the development of metastases in men who receive androgen‐deprivation therapy for a biochemical recurrence after radical prostatectomy?Vidal, Adriana C. / Howard, Lauren E. / De Hoedt, Amanda / Kane, Christopher J. / Terris, Martha K. / Aronson, William J. / Cooperberg, Matthew R. / Amling, Christopher L. / Lechpammer, Stanislav / Flanders, Scott C. et al. | 2019
- 442
-
Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: An Australian population‐based studyYe, Yuanzi / Otahal, Petr / Marwick, Thomas H. / Wills, Karen E. / Neil, Amanda L. / Venn, Alison J. et al. | 2019
- 453
-
Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancerBorno, Hala T. / Lichtensztajn, Daphne Y. / Gomez, Scarlett L. / Palmer, Nynikka R. / Ryan, Charles J. et al. | 2019
- 463
-
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF‐mutated melanoma and other advanced malignanciesBhatty, Minny / Kato, Shumei / Piha‐Paul, Sarina A. / Naing, Aung / Subbiah, Vivek / Huang, Helen J. / Karp, Daniel D. / Tsimberidou, Apostolia M. / Zinner, Ralph G. / Hwu, Wen‐Jen et al. | 2019
- 473
-
Unmet social support needs among older adults with cancerWilliams, Grant R. / Pisu, Maria / Rocque, Gabrielle B. / Williams, Courtney P. / Taylor, Richard A. / Kvale, Elizabeth A. / Partridge, Edward E. / Bhatia, Smita / Kenzik, Kelly M. et al. | 2019
- 482
-
Risk factors for hepatocellular carcinomaLai, Shih‐Wei et al. | 2019
- 483
-
Reply to Risk factors for hepatocellular carcinomaYi, Sang‐Wook / Choi, Ja‐Sung et al. | 2019